TMEM116: A Potential Drug Target Or Biomarker (G89894)

Target Name: TMEM116

NCBI ID: G89894

TMEM116

TMEM116: A Potential Drug Target Or Biomarker

TMEM116 (Tissue Membrane Explion-116) is a protein that is expressed in various tissues and cells in the body. It is a member of the transmembrane protein family and is involved in the regulation of various cellular processes. One of the unique features of TMEM116 is its ability to interact with various signaling molecules, including TGF-β1, PDGF, and NF-kappa-B. This interaction has led to the hypothesis that TMEM116 may be a drug target or biomarker for various diseases.

The TMEM116 protein is composed of 150 amino acid residues and has a calculated molecular weight of 19.9 kDa. It is expressed in a variety of tissues, including the brain, heart, liver, and kidney. TMEM116 is primarily localized to the cell membrane and is involved in the regulation of various cellular processes, including cell adhesion, migration, and signaling.

One of the most significant functions of TMEM116 is its ability to interact with signaling molecules. TMEM116 has been shown to interact with TGF-β1, PDGF, and NF-kappa-B, among other signaling molecules. These interactions are critical for the regulation of cellular processes , including cell growth, differentiation, and inflammation.

The interaction between TMEM116 and TGF-β1 is particularly interesting. TGF-β1 is a well-known signaling molecule that plays a critical role in the regulation of cellular processes, including cell growth, differentiation, and inflammation. 尾1 has been shown to be important for the regulation of cell adhesion and migration.

TMEM116 has also been shown to interact with PDGF, a signaling molecule that plays a critical role in the regulation of cellular processes, including cell growth, differentiation, and survival. The interaction between TMEM116 and PDGF has been shown to be important for the regulation of cell proliferation and survival.

In addition to its interactions with TGF-β1 and PDGF, TMEM116 has also been shown to interact with NF-kappa-B, a signaling molecule that plays a critical role in the regulation of cellular processes, including inflammation and stress. The interaction between TMEM116 and NF -kappa-B has been shown to be important for the regulation of inflammation and stress responses.

The interaction between TMEM116 and these signaling molecules has led to the hypothesis that TMEM116 may be a drug target or biomarker for various diseases. For example, TMEM116 has been shown to be involved in the regulation of cell adhesion and migration, which may be relevant to diseases such as cancer and neurodegenerative disorders. Additionally, TMEM116 has been shown to interact with TGF-β1, which may be relevant to diseases such as autoimmune diseases. The interaction between TMEM116 and PDGF has also been shown to be important for the regulation of cell proliferation and survival, which may be relevant to diseases such as cancer.

In conclusion, TMEM116 is a protein that is expressed in various tissues and cells in the body and is involved in the regulation of various cellular processes. The interaction between TMEM116 and various signaling molecules, including TGF-β1, PDGF, and NF-kappa-B, has led to the hypothesis that TMEM116 may be a drug target or biomarker for various diseases. Further research is needed to confirm this hypothesis and to determine the full range of functions of TMEM116.

Protein Name: Transmembrane Protein 116

The "TMEM116 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about TMEM116 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets